Route 92 Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
197
- Latest Deal Type
-
General Corporate Purpose
- Latest Deal Amount
-
$100M
- Investors
-
6
Route 92 General Information
Description
Developer of neurovascular intervention devices designed to improve outcomes for patients with vascular conditions in the brain. The company offers advanced catheter systems and reperfusion technology for precise navigation and clot removal, enabling healthcare providers to perform complex neuro-intervention procedures with improved access and treatment efficiency.
Contact Information
Website
www.route92medical.comCorporate Office
- 1375 West 8040 South
- West Jordan, UT 84088
- United States
Corporate Office
- 1375 West 8040 South
- West Jordan, UT 84088
- United States
Route 92 Timeline
Route 92 Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. General Corporate Purpose | 20-Oct-2026 | $100M | Completed | Generating Revenue | ||
| 10. Later Stage VC (Series F) | 07-Apr-2026 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series F) | 12-Jul-2024 | Completed | Generating Revenue | |||
| 8. General Corporate Purpose | 12-Jan-2024 | Completed | Generating Revenue | |||
| 7. Debt - General | 17-Aug-2021 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series E) | 13-Jul-2021 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series D) | 10-May-2019 | Completed | Startup | |||
| 4. Debt - General | Completed | Startup | ||||
| 3. Later Stage VC (Series C) | 17-Aug-2018 | $4.73M | $16.5M | Completed | Startup | |
| 2. Early Stage VC (Series B) | 02-May-2017 | $5.86M | $11.8M | Completed | Startup |
Route 92 Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series F-2 | ||||||||
| Series F | ||||||||
| Series E | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | 1,758,700 | $0.000100 | $0.21 | $3.5 | $3.5 | 1x | $3.5 | 4.08% |
| Series A | 2,360,000 | $0.000100 | $0.15 | $2.5 | $2.5 | 1x | $2.5 | 5.48% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Route 92 Comparisons
Industry
Financing
Details
Route 92 Competitors (17)
One of Route 92’s 17 competitors is Q'Apel, a Venture Capital-Backed company based in Fremont, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Q'Apel | Venture Capital-Backed | Fremont, CA | ||||
| Perfuze | Venture Capital-Backed | Galway, Ireland | ||||
| Artiria Medical | Venture Capital-Backed | Geneva, Switzerland | ||||
| Imperative Care | Venture Capital-Backed | Campbell, CA | ||||
| BrainsGate | Venture Capital-Backed | Caesarea, Israel |
Route 92 Patents
Route 92 Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026156233-A1 | An intravascular guiding sheath | Pending | 17-Jan-2025 | ||
| US-20260207896-A1 | Guiding sheath, sheath systems, and methods of use | Pending | 17-Jan-2025 | ||
| WO-2026076348-A1 | Neurocatheter | Pending | 04-Oct-2024 | ||
| US-20260097183-A1 | Neurocatheters, systems, and methods of use | Pending | 04-Oct-2024 | ||
| US-20250221834-A1 | Systems and methods for treating vascular disease | Pending | 09-Jan-2024 | A61F2/89 |
Route 92 Signals
Route 92 Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Sectoral Asset Management | Venture Capital | Minority | ||
| Novo Holdings | Venture Capital | Minority | ||
| InnovaHealth Partners | Growth/Expansion | Minority | ||
| The Vertical Group | Venture Capital | Minority | ||
| Norwest | Venture Capital | Minority |
Route 92 FAQs
-
When was Route 92 founded?
Route 92 was founded in 2015.
-
Where is Route 92 headquartered?
Route 92 is headquartered in West Jordan, UT.
-
What is the size of Route 92?
Route 92 has 197 total employees.
-
What industry is Route 92 in?
Route 92’s primary industry is Surgical Devices.
-
Is Route 92 a private or public company?
Route 92 is a Private company.
-
What is Route 92’s current revenue?
The current revenue for Route 92 is .
-
How much funding has Route 92 raised over time?
Route 92 has raised $394M.
-
Who are Route 92’s investors?
Sectoral Asset Management, Novo Holdings, InnovaHealth Partners, The Vertical Group, and Norwest are 5 of 6 investors who have invested in Route 92.
-
Who are Route 92’s competitors?
Q'Apel, Perfuze, Artiria Medical, Imperative Care, and BrainsGate are some of the 17 competitors of Route 92.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process